Related Experiment Videos
E2F4 loss suppresses tumorigenesis in Rb mutant mice
Eunice Y Lee1, Hieu Cam, Ulrike Ziebold
1Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Cancer Cell
|December 25, 2002
Summary
Loss of E2F4, a key repressive transcription factor, prevents tumor development in mice lacking the retinoblastoma protein (pRB). This occurs through a novel mechanism involving p107 and p130 regulating other E2F factors.
Area of Science:
- * Molecular Biology
- * Cancer Biology
- * Genetics
Background:
- * E2F transcription factors regulate cell cycle genes.
- * Retinoblastoma protein (pRB) and its relatives (p107, p130) are tumor suppressors.
- * E2F4 is a major repressive E2F family member.
Purpose of the Study:
- * To investigate the role of E2F4 in pRB's tumor-suppressive function.
- * To understand the mechanism by which E2F4 loss impacts tumorigenesis.
Main Methods:
- * Analysis of Rb(+/-) mice with and without E2F4.
- * Biochemical analyses of E2F complexes.
- * Assessment of gene expression and cell proliferation in pRB-deficient cells.
Main Results:
- * E2F4 loss significantly suppressed pituitary and thyroid tumor development in Rb(+/-) mice.
- * E2F4 deficiency prevented aberrant gene expression and proliferation in pRB-deficient cells.
- * A novel mechanism was identified where E2F4 loss enables p107 and p130 to regulate pRB-specific activator E2Fs.
Conclusions:
- * E2F4 plays a critical role in pRB-mediated tumor suppression.
- * Novel E2F complexes involving p107/p130 and activator E2Fs are important in regulating tumorigenesis.
- * Targeting E2F4 could be a therapeutic strategy for pRB-deficient cancers.